We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$228M
AUM Growth
+$28.2M
Cap. Flow
+$16.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
22.49%
Holding
2,261
New
155
Increased
919
Reduced
268
Closed
73

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$3.24M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.22M
3
VGT icon
Vanguard Information Technology ETF
VGT
+$1.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.05M
5
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
+$1.04M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$12.5M
2
HD icon
Home Depot
HD
+$5.18M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$555K
4
ESRX
Express Scripts Holding Company
ESRX
+$401K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$401K

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Healthcare 8.96%
3 Consumer Staples 8.9%
4 Technology 8.86%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
751
Aptiv
APTV
$12B
$14K 0.01%
201
+114
+131% +$8.56K
ARE icon
752
Alexandria Real Estate Equities
ARE
$8.88B
$14K 0.01%
152
+30
+25% +$3.39K
ASX icon
753
ASE Group
ASX
$80.8B
$14K 0.01%
2,755
+557
+25% +$3.32K
BAP icon
754
Credicorp
BAP
$30.9B
$14K 0.01%
103
+4
+4% +$658
BLUE
755
DELISTED
bluebird bio
BLUE
$14K 0.01%
12
– –
CGNX icon
756
Cognex
CGNX
$10.3B
$14K 0.01%
374
+88
+31% +$3.22K
CHE icon
757
Chemed
CHE
$6.78B
$14K 0.01%
86
+15
+21% +$2.62K
CX icon
758
Cemex
CX
$17.4B
$14K 0.01%
1,872
+112
+6% +$942
DEI icon
759
Douglas Emmett
DEI
$2.06B
$14K 0.01%
412
+74
+22% +$2.84K
DOX icon
760
Amdocs
DOX
$5.53B
$14K 0.01%
240
-26
-10% -$1.56K
EXAS
761
DELISTED
Exact Sciences
EXAS
$14K 0.01%
597
– –
FE icon
762
FirstEnergy
FE
$28.9B
$14K 0.01%
510
-376
-42% -$11.6K
HP icon
763
Helmerich & Payne
HP
$3.53B
$14K 0.01%
252
-62
-20% -$4.41K
IRM icon
764
Iron Mountain
IRM
$38.2B
$14K 0.01%
497
– –
JD icon
765
JD.com
JD
$40.8B
$14K 0.01%
498
+418
+523% +$12.3K
JKHY icon
766
Jack Henry & Associates
JKHY
$10.7B
$14K 0.01%
173
– –
KEX icon
767
Kirby Corp
KEX
$7.95B
$14K 0.01%
227
+41
+22% +$2.8K
MEOH icon
768
Methanex
MEOH
$4.32B
$14K 0.01%
324
– –
NHI icon
769
National Health Investors
NHI
$3.9B
$14K 0.01%
195
– –
NVR icon
770
NVR
NVR
$17.2B
$14K 0.01%
7
+4
+133% +$7.58K
PAYX icon
771
Paychex
PAYX
$40.4B
$14K 0.01%
271
– –
PHM icon
772
Pultegroup
PHM
$24.5B
$14K 0.01%
653
– –
RITM icon
773
Rithm Capital
RITM
$5.09B
$14K 0.01%
857
– –
SKM icon
774
SK Telecom
SKM
$13.7B
$14K 0.01%
388
+20
+5% +$747
TDG icon
775
TransDigm Group
TDG
$69.2B
$14K 0.01%
83
-133
-62% -$31.7K
29 30
31
32 33

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q1 2017 Portfolio in Review

As of Q1 2017, Quadrant Capital Group held 2,261 positions worth $228M, up 14% from $199M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrant Capital Group deployed $16.3M of net new capital in Q1 2017, opening 155 new positions and adding to 919 existing holdings. Its largest new stake was Meridian Bioscience Inc: 158,483 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $12.5M trimmed.

  • Quadrant Capital Group's largest Q1 2017 buy was Meridian Bioscience Inc: 158,483 shares worth $2.19M.
  • Quadrant Capital Group added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $3.24M increase.
  • Quadrant Capital Group's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $12.5M.
  • Quadrant Capital Group fully exited Harman International Industries in Q1 2017, selling an estimated $104K.
  • Quadrant Capital Group's ten largest holdings make up 22% of its $228M portfolio in Q1 2017.
  • Quadrant Capital Group opened 155 new positions and closed 73 in Q1 2017.
  • Quadrant Capital Group's portfolio value rose 14% quarter-over-quarter to $228M.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.